Deep Learning Models Capture Histological Disease Activity in Crohn's Disease and Ulcerative Colitis with High
Dawid Rymarczyk1,2, Weiwei Schultz3, Adriana Borowa1,2
1AI Lab, Ardigen SA, Kraków, Poland.
Journal of Crohn'S & Colitis
|October 9, 2023
Summary
Deep learning models accurately assess histological disease activity in inflammatory bowel disease (IBD), aiding drug development. These AI tools show strong agreement with expert pathologists for Crohn's disease (CD) and ulcerative colitis (UC).
Area of Science:
- Gastroenterology
- Computational Pathology
- Artificial Intelligence
Background:
- Histological disease activity is crucial for clinical outcomes and drug development in inflammatory bowel disease (IBD).
- Automating histological assessments in IBD is essential for efficient and objective evaluation.
Purpose of the Study:
- To develop and evaluate deep learning models for automating histological assessments in IBD.
- To compare the performance of different AI methods in predicting histological disease activity scores.
Main Methods:
- Histology images from Crohn's disease (CD) and ulcerative colitis (UC) clinical trials were used to train AI models.
- Models predicted the Global Histology Activity Score (GHAS) for CD and Geboes score for UC.
- AI model predictions were compared against expert central readings and independent pathologists.
Main Results:
- A self-attention-based multiple instance learning model (SA-AbMILP) showed superior performance.
- AI-predicted GHAS and Geboes subgrades demonstrated moderate to substantial agreement with central readings (65-89% accuracy).
- The model accurately distinguished histological features in CD and UC across different anatomical locations (76-94% accuracy).
Conclusions:
- Deep learning models effectively distinguish microscopic disease activity in IBD based on established scoring systems.
- AI-driven histological assessment shows comparable accuracy to human pathologists, supporting its use in clinical trials.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
264
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
264
Inflammatory Bowel Disease I: Ulcerative Colitis
196
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
196


